3//SEC Filing
Therapeutics Acquisition Holdings LLC 3
Accession 0001104659-20-081868
CIK 0001811764other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 9:58 PM ET
Size
5.0 KB
Accession
0001104659-20-081868
Insider Transaction Report
Form 3
Holdings
Class B Common Stock
Exercise: $0.00→ Class A Common Stock (2,785,000 underlying)
Footnotes (2)
- [F1]The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the issuer's initial business combination or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for stock splits, stock capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.
- [F2]The shares of Class B common stock owned by the Reporting Person includes up to 375,000 shares that are subject to forfeiture in the event the underwriters of the initial public offering of the issuer's securities do not exercise in full their over-allotment option as described in the issuer's registration statement.
Documents
Issuer
Therapeutics Acquisition Corp.
CIK 0001811764
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001817046
Filing Metadata
- Form type
- 3
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 9:58 PM ET
- Size
- 5.0 KB